These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15633864

  • 21. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    Amsterdam JD, Shults J.
    J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
    [Abstract] [Full Text] [Related]

  • 22. Does olanzapine have any antidepressant effect?
    Moreira-Almeida A, Pietrobon R.
    Am J Psychiatry; 2006 Oct; 163(10):1838-9; author reply 1839. PubMed ID: 17012700
    [No Abstract] [Full Text] [Related]

  • 23. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF.
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [Abstract] [Full Text] [Related]

  • 24. Aripiprazole augmentation of venlafaxine in the treatment of psychogenic excoriation.
    Carter WG, Shillcutt SD.
    J Clin Psychiatry; 2006 Aug; 67(8):1311. PubMed ID: 16965218
    [No Abstract] [Full Text] [Related]

  • 25. [The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
    D'iakonov AL, Lobanova IV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012 Aug; 112(11 Pt 2):61-6. PubMed ID: 23257758
    [Abstract] [Full Text] [Related]

  • 26. Influence of fluoxetine on olanzapine pharmacokinetics.
    Gossen D, de Suray JM, Vandenhende F, Onkelinx C, Gangji D.
    AAPS PharmSci; 2002 Aug; 4(2):E11. PubMed ID: 12102620
    [Abstract] [Full Text] [Related]

  • 27. Use of olanzapine in anorexia nervosa.
    Menaster M.
    J Clin Psychiatry; 2005 May; 66(5):654-5; author reply 655-6. PubMed ID: 15889956
    [No Abstract] [Full Text] [Related]

  • 28. Fluoxetine in the treatment of self-mutilating behavior.
    Velazquez L, Ward-Chene L, Loosigian SR.
    J Am Acad Child Adolesc Psychiatry; 2000 Jul; 39(7):812-4. PubMed ID: 10892222
    [No Abstract] [Full Text] [Related]

  • 29. Olanzapine augmentation for treatment-resistant obsessive-compulsive disorder.
    Koran LM, Ringold AL, Elliott MA.
    J Clin Psychiatry; 2000 Jul; 61(7):514-7. PubMed ID: 10937610
    [Abstract] [Full Text] [Related]

  • 30. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
    Andersen SW, Clemow DB, Corya SA.
    J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
    [Abstract] [Full Text] [Related]

  • 31. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
    Poyurovsky M, Pashinian A, Gil-Ad I, Maayan R, Schneidman M, Fuchs C, Weizman A.
    Am J Psychiatry; 2002 Jun; 159(6):1058-60. PubMed ID: 12042201
    [Abstract] [Full Text] [Related]

  • 32. Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.
    Houston JP, Lau K, Aris V, Liu W, Fijal BA, Heinloth AN, Perlis RH.
    J Clin Psychiatry; 2012 Jun; 73(6):878-85. PubMed ID: 22480387
    [Abstract] [Full Text] [Related]

  • 33. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
    Brown E, Dunner DL, McElroy SL, Keck PE, Adams DH, Degenhardt E, Tohen M, Houston JP.
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
    [Abstract] [Full Text] [Related]

  • 34. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC.
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [Abstract] [Full Text] [Related]

  • 35. Treatment of self-mutilation with olanzapine.
    Garnis-Jones S, Collins S, Rosenthal D.
    J Cutan Med Surg; 2000 Jul; 4(3):161-3. PubMed ID: 11003723
    [Abstract] [Full Text] [Related]

  • 36. Fluoxetine for the treatment of compulsive facial picking.
    Stout RJ.
    Am J Psychiatry; 1990 Mar; 147(3):370. PubMed ID: 2309961
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder.
    Coccaro EF, Lee RJ, Kavoussi RJ.
    J Clin Psychiatry; 2009 Apr 21; 70(5):653-62. PubMed ID: 19389333
    [Abstract] [Full Text] [Related]

  • 39. Olanzapine augmentation in panic disorder: a case report.
    Chao I.
    Pharmacopsychiatry; 2004 Sep 21; 37(5):239-40. PubMed ID: 15470803
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.